韦莱韬悦：2023年全球生命科学风险展望报告（英文版）（30页）.pdf

《韦莱韬悦：2023年全球生命科学风险展望报告（英文版）（30页）.pdf》由会员分享，可在线阅读，更多相关《韦莱韬悦：2023年全球生命科学风险展望报告（英文版）（30页）.pdf（30页珍藏版）》请在三个皮匠报告上搜索。

1、Global Life Sciences Risk Outlook 2023Managing emerging risks,challenges and opportunities in the life science sector WTW Global Life Science S2/Global Life Sciences Risk Outlook 2023Opportunity and uncertainty in a time of rapid change The global pandemic was a watershed for the life science indust

2、ry.Businesses were forced not just to embrace new technologies and working methods,but to rethink existing operating models in order to deliver innovation at speed.This has left a deep impact,accelerating changes that will shape the sector for years to come from new clinical trial models and regulat

3、ory approval processes to digitalization and automation of processes.Though hugely promising,these rapid advances can be difficult to adapt to in the short term.They also raise ethical and legal questions around issues such as data privacy and health equity.How is the industry adapting?To find out w

4、hat the industry is thinking about these trends,and a range of other opportunities,risks and challenges,we asked more than 600 industry leaders and decision-makers for their views.Our respondents come from many different global regions and from a cross-section of businesses representing the life sci

5、ence ecosystem.Embracing change with cautionWe found that companies are conflicted about the rapid pace of change.In some cases,they see the same emerging themes such as adaptive,decentralized and hybrid clinical trials as having both strong positive and negative impacts on their businesses.As the s

6、ector becomes more dependent on data to inform strategy and drive innovation,firms are also more conscious of risks related to how that data is used and to getting appropriately informed consent.In a time of continuing uncertainty,many firms are looking to industry collaborations and strategic acqui